SEARCHGUIDELINESgeriatrics, internal medicine

guidelines·geriatrics, internal medicine, nutrition, endocrinology, family medicine·PMC10610956

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update

CMAJ : Canadian Medical Association Journal · 38 authors, 1 centre

AI SUMMARY

FIDELITY 100%

This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.

AGENT 01 · STRUCTURED SUMMARY

TRACE TO SOURCE

“

TL;DR

The Osteoporosis Canada 2023 guideline update was developed by a volunteer group using the GRADE framework and AGREE II standards.

Full summary

504 CHARS

The Osteoporosis Canada 2023 guideline update was developed by a volunteer group using the GRADE framework and AGREE II standards. The aim is to empower discussions on skeletal health, with the potential to reduce fractures and preserve quality of life. Key limitations include the exclusion of topics like fall prevention and management of secondary osteoporosis, reliance on indirect evidence for some recommendations (e.g., in males), and a literature search process that was not continuously updated.

STUDY TYPE

guidelines

SPECIALTY

geriatrics

SUMMARISED BY

AI pipeline

FIDELITY CHECK

100% · A

ORIGINAL PAPER

PMC10610956

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update

CMAJ : Canadian Medical Association Journal

READ THE FULL PAPER

ABSTRACT

Background: In Canada, more than 2 million people live with osteoporosis, a disease that increases the risk for fractures, which result in excess mortality and morbidity, decreased quality of life and loss of autonomy. This guideline update is intended to assist Canadian health care professionals in the delivery of care to optimize skeletal health and prevent fractures in postmenopausal females and in males aged 50 years and older. Methods: This guideline is an update of the 2010 Osteoporosis Canada clinical practice guideline on the diagnosis and management of osteoporosis in Canada. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework and quality assurance as per Appraisal of Guidelines for Research and Evaluation (AGREE II) quality and reporting standards. Primary care physicians and patient partners were represented at all levels of the guideline committees and groups, and participated throughout the entire process to ensure relevance to target users. The process for managing competing interests was developed before and continued throughout the guideline development, informed by the Guideline International Network principles. We considered benefits and harms, patient values and preferences, resources, equity, acceptability and feasibility when developing recommendations; the strength of each recommendation was assigned according to the GRADE framework. Recommendations The 25 recommendations and 10 good practice statements are grouped under the sections of exercise, nutrition, fracture risk assessment and treatment initiation, pharmacologic interventions, duration and sequence of therapy, and monitoring. The management of osteoporosis should be guided by the patient’s risk of fracture, based on clinical assessment and using a validated fracture risk assessment tool. Exercise, nutrition and pharmacotherapy are key elements of the management strategy for fracture prevention and should be individualized. Interpretation: The aim of this guideline is to empower health care professionals and patients to have meaningful discussions on the importance of skeletal health and fracture risk throughout older adulthood. Identification and appropriate management of skeletal fragility can reduce fractures, and preserve mobility, autonomy and quality of life.

CITATION EXPORT

Suzanne N. Morin, Sidney Feldman, Larry Funnell et al.. Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. CMAJ : Canadian Medical Association Journal. (2023). https://doi.org/10.1503/cmaj.221647

AUTHORS

38 · 1 CENTRES

Suzanne N. Morin, Sidney Feldman, Larry Funnell, Lora Giangregorio, Sandra Kim, Heather McDonald-Blumer, Nancy Santesso, Rowena Ridout, Wendy Ward, Maureen C. Ashe, Zahra Bardai, Joan Bartley, Neil Binkley, Steven Burrell, Debra Butt, Suzanne M. Cadarette, Angela M. Cheung, Phil Chilibeck, Sheila Dunn, Jamie Falk, Heather Frame, William Gittings, Kaleen Hayes, Carol Holmes, George Ioannidis, Susan B. Jaglal, Robert Josse, Aliya A. Khan, Virginia McIntyre, Lynn Nash, Ahmed Negm, Alexandra Papaioannou, Matteo Ponzano, Isabel B. Rodrigues, Lehana Thabane, Christine A. Thomas, Lianne Tile, John D. Wark

McGill University (Morin), Montréal, Que.; University of Toronto (Feldman, Kim, McDonald-Blumer, Ridout, Cheung, Josse, Tile, Bardai, Butt, Cadarette, Dunn, Jaglal), Toronto, Ont.; patient partners (Funnell, McIntyre, Bartley, Thomas); University of Waterloo (Giangregorio, Kim, McLaughlin, Rodrigues), Waterloo, Ont.; Brock University (Ward, Gittings), St. Catharines, Ont.; McMaster University (Santesso, Ioannidis, Khan, Nash, Thabane, Papaioannou), Hamilton, Ont.; University of Wisconsin (Binkley), Madison, Wisc.; Dalhousie University (Burrell), Halifax, NS; Menzies Medical Centre (Holmes), Morden, Man.; University of Calgary (Negm), Calgary, Alta.; University of British Columbia (Ashe), Vancouver, BC; University of Saskatchewan (Chilibeck), Saskatoon, Sask.; University of British Columbia (Ponzano), Kelowna, BC; University of Melbourne (Wark), Melbourne, Australia; University of Manitoba (Falk, Frame), Winnipeg, Man.; Brown University (Hayes), Providence, RI.